Apollo Silver to Option Cinco de Mayo Project, Chihuahua, Mexico

VANCOUVER, British Columbia, Sept. 23, 2024 (GLOBE NEWSWIRE) — Apollo Silver Corp. (“Apollo Silver” or the “Company“) (TSX.V:APGO, OTCQB:APGOF, Frankfurt:6ZF0) has entered into an exploration, earn-in and option agreement (the “Option Agreement“), dated effective September 20, 2024, with MAG Silver Corp. (“MAG“) (TSX:MAG) and its subsidiary, Minera Pozo Seco, S.A. de C.V. (“MPS“), pursuant to […]

Evasant Announces Renewed Focus on Sustainability

HANGZHOU, China, Sept. 23, 2024 (GLOBE NEWSWIRE) — Evasant is proud to announce the enhancement of its sustainability and diversity, equity, and inclusion (DEI) policies, furthering its commitment to responsible business practices. These strengthened policies reaffirm Evasant’s dedication to driving positive environmental impact and fostering a more inclusive corporate culture. Strengthening Our Sustainability Commitment As

Mölnlycke and Ondine join forces against HAIs

Mölnlycke Health Care partners with Ondine for Steriwave distribution collaboration in the key markets of the UK, Europe and the Middle East. Gothenburg, Sweden 23 September 2024. Mölnlycke® Health Care, a world-leading MedTech company that specialises in innovative solutions for wound care and surgical procedures and Ondine Biomedical Inc. (LON: OBI), a Canadian life sciences

Biocomposites to showcase innovations in infection management at EBJIS 2024

— Biocomposites-sponsored symposium to focus on how to improve outcomes in complex periprosthetic joint infection (PJI) cases, with insights from leading surgeons — Abstract by Biocomposites’ researchers shows how calcium sulfate beads loaded with antifungals are effective in inhibiting drug-resistant strains of Candida auris Biocomposites, an international medical devices company that engineers, manufactures and markets

Creative Group Named to the MeetingsNet 2024 CMI 25 List

It’s the 18th year that MeetingsNet has recognized the largest and most influential meeting and incentive travel companies in North America, and Creative Group has once again made the list. Creative Group announced today that for the 18th year in a row, it has been named to MeetingsNet’s 2024 CMI 25 list, honoring the largest

Professor Luo Min Appointed as Chairman of Spine Neurocardiology Interdisciplinary Professional Committee in China to Promote Development of Innovative Heart Disease Treatments

ProfessorLuo Min, Doctor of Medicine (MD), from Beijing Yuhe Integrated Traditional Chinese and Western Medicine Rehabilitation Hospital, was recently appointed as the Chairman of the National AssociationofHealth IndustryandEnterprise Management(NAHIEM) Spine Neurocardiology Interdisciplinary Professional Committee and the Head of the Preparatory Group, in recognition of his contributionsto the field of spinal nerve and heart disease treatment.

LIFT reports laboratory metallurgical recoveries averaging 79% producing a high-quality spodumene concentrate grading 5.83% Li2O at the Yellowknife Lithium Project

VANCOUVER, British Columbia, Sept. 23, 2024 (GLOBE NEWSWIRE) — Li-FT Power Ltd. (“LIFT” or the “Company“) (TSXV: LIFT) (OTCQX: LIFFF) (Frankfurt: WS0) is pleased to report results from the metallurgical sampling program completed in 2023 and 2024 across eight spodumene deposits within the Yellowknife Lithium Project, Northwest Territories, Canada. Metallurgical test work comprised of heavy

Repurchase of Truecaller B shares in week 38, 2024

During 16 September 2024 and 20 September 2024 Truecaller AB (publ) (LEI code 549300TEYF1FA5G5GK26) has repurchased in total 150,000 own B shares (ISIN: SE0016787071), corresponding to 0.04% of outstanding capital, as part of the share buyback programme initiated by the board of directors. Since the start of the programme, in the end of May, 3.17

Vicebio Announces $100 Million Series B Financing and Initiation of Phase 1 Clinical Study of RSV/hMPV Bivalent Vaccine

— Financing led by new investorTCGX, alongside Goldman Sachs Alternatives, Avoro Ventures and venBio — Funding will support and accelerate development of next-generation multivalent respiratory virus vaccines using proprietary Molecular Clamp technology — Commenced Phase I clinical study of bivalent vaccine targeting both RespiratorySyncytial Virus (RSV) and Human Metapneumovirus (hMPV) Vicebio Ltd (“Vicebio”), a biopharmaceutical

FluoRok raises £7.7m ($9.8m) to transform the safety and sustainability of fluorochemical production

FluoRok, an Oxford-based start-up, has raised £7.7m to scale-up, manufacture and commercialise novel fluorochemical reagents and battery electrolyte salts. The oversubscribed round was led by BGF alongside Green Generation Fund and included battery specialist Volta Energy Technologies, current investors (Oxford Science Enterprises and University of Oxford), Excellis Holding and angels. https://mma.prnewswire.com/media/2507383/FluoRok_Limited_Team.jpg Founded in 2022, FluoRok

Scroll to Top